Histopathology

Papers
(The TQCC of Histopathology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction942
The 2019 World Health Organization classification of tumours of the breast383
Pulmonary and systemic involvement in COVID‐19 patients assessed with ultrasound‐guided minimally invasive autopsy239
Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD159
Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours116
Third‐trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐positive women: histomorphology, including viral immunohistochemistry and in‐situ hybridization109
Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies86
Pulmonary pathology of early‐phase COVID‐19 pneumonia in a patient with a benign lung lesion78
Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID‐19 pneumonia in Wuhan, China77
Hunting coronavirus by transmission electron microscopy – a guide to SARS‐CoV‐2‐associated ultrastructural pathology in COVID‐19 tissues73
NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma62
Identifying mismatch repair‐deficient colon cancer: near‐perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population‐based series58
When used together SS18–SSX fusion‐specific and SSX C‐terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in54
Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)54
Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases53
Evolving classification of rhabdomyosarcoma51
Transarterial chemoembolisation enhances programmed death‐1 and programmed death‐ligand 1 expression in hepatocellular carcinoma50
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma46
Primary high‐grade non‐anaplastic thyroid carcinoma: a retrospective study of 364 cases44
Performance of the pattern‐based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma43
Looking into digestive mixed neuroendocrine – nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors41
PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna40
Addition of the tumour–stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma39
Updates on spread through air spaces (STAS) in lung cancer39
An introduction to the WHO 5th edition 2022 classification of testicular tumours36
The diversity of tumours with microsatellite instability: molecular mechanisms and impact upon microsatellite instability testing and mismatch repair protein immunohistochemistry34
Gastric neuroendocrine tumours from long‐term proton pump inhibitor users are indolent tumours with good prognosis33
Computerised scoring protocol for identification and quantification of different immune cell populations in breast tumour regions by the use of QuPath software33
Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33–RET fusions and BRAF V600E mutations33
Poorly differentiated clusters in colorectal cancer: a current review and implications for future practice32
Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical implications32
Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features32
Pleomorphic adenoma: the great mimicker of malignancy31
Non‐conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia31
An update on the pathological classification of breast cancer31
The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real‐time polymerase chain reaction30
Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes28
Artificial intelligence and algorithmic computational pathology: an introduction with renal allograft examples28
The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression27
Head to head: should the intraductal component of invasive prostate cancer be graded?27
Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters27
Mesenchymal neoplasms with NTRK and other kinase gene alterations27
Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis26
Metastasis to the thyroid gland: a single‐institution 16‐year experience26
Development and validation of a supervised deep learning algorithm for automated whole‐slide programmed death‐ligand 1 tumour proportion score assessment in non‐small cell lung cancer26
Sry‐related high‐mobility‐group/HMG box 10 (SOX10) as a sensitive marker for triple‐negative breast cancer26
Recent advances in the pathology of heritable gastric cancer syndromes26
Gastrointestinal tissue‐based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours25
Medication‐specific variations in morphological patterns of injury in immune check‐point inhibitor‐associated colitis25
Superficial CD34‐positive fibroblastic tumor and PRDM10‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases25
Adenomyoepithelioma of the breast: a proposal for classification25
Undifferentiated endometrial carcinoma arising in the background of high‐grade endometrial carcinoma – Expanding the definition of dedifferentiated endometrial carcinoma25
Identification of EWSR1–NFATC2 fusion in simple bone cysts25
Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis25
Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue24
Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous lesions in the vulva24
COVID‐19 related lung pathology: old patterns in new clothing?24
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification23
Histopathological diagnosis of tumour deposits in colorectal cancer: a Delphi consensus study23
Evaluating programmed death‐ligand 1 (PD‐L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study23
Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading23
Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma23
The prognostic significance of ALDH1A1 expression in early invasive breast cancer23
Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence‐free survival in stages I–III colore23
Social media in academics and research: 21st‐century tools to turbocharge education, collaboration, and dissemination of research findings22
Hepatocellular adenoma: what we know, what we do not know, and why it matters22
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms21
Feasibility and accuracy of pathological diagnosis in en‐bloc transurethral resection specimens versus conventional transurethral resection specimens of bladder tumour: evaluation with pT1 substaging 21
A multicentre analytical comparison study of inter‐reader and inter‐assay agreement of four programmed death‐ligand 1 immunohistochemistry assays for scoring in triple‐negative breast cancer21
Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability 21
MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics20
Diagnostic variability in the histopathological assessment of advanced colorectal adenomas and early colorectal cancer in a screening population20
PRAME is a useful marker for the differential diagnosis of melanocytic tumours and histological mimics20
Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor‐1 and neuroendocrine markers20
p53 immunohistochemical analysis of fusion‐positive uterine sarcomas20
Low‐grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity19
Spitz melanocytic tumours – a review19
Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies19
Non‐conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum19
Hereditary breast cancer: syndromes, tumour pathology and molecular testing19
Mismatch repair deficiency is rare in bone and soft tissue tumors18
Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy18
Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status18
Clinicopathological findings in patients with COVID‐19‐associated ischaemic enterocolitis17
The pathology of gastric and duodenal polyps: current concepts17
Radiation‐associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation17
Automated assessment of Ki‐67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging17
The future of artificial intelligence in digital pathology – results of a survey across stakeholder groups17
Elastin in pulmonary pathology: relevance in tumours with a lepidic or papillary appearance. A comprehensive understanding from a morphological viewpoint17
Clinicopathological and molecular characterisation of USP6‐rearranged soft tissue neoplasms: the evidence of genetic relatedness indicates an expanding family with variable bone‐forming capacit17
Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study17
Targeted therapy for upper gastrointestinal tract cancer: current and future prospects17
Colitis‐associated colorectal adenocarcinomas frequently express claudin 18 isoform 2: implications for claudin 18.2 monoclonal antibody therapy17
The histopathology of congenital haemangioma and its clinical correlations: a long‐term follow‐up study of 55 cases17
Gene fusion characterisation of rare aggressive prostate cancer variants—adenosquamous carcinoma, pleomorphic giant‐cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases17
Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial17
Taking tumour budding to the next frontier — a post International Tumour Budding Consensus Conference (ITBCC) 2016 review17
Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3‐MAML2 fusions, and clinicopathological features17
Benign infiltrative myofibroblastic neoplasms of childhood with USP6 gene rearrangement16
Cutaneous histiocytoses in children16
Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens16
Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma16
Mucinous adenocarcinoma arising in congenital pulmonary airway malformation: clinicopathological analysis of 37 cases16
A case of pericytic neoplasm in the shoulder with a novel DERA–GLI1 gene fusion16
p16 Immunoexpression in sinonasal and nasopharyngeal adenoid cystic carcinomas: a potential pitfall in ruling out HPV‐related multiphenotypic sinonasal carcinoma16
Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve‐sparing surgery in prostate cancer patients (NeuroSAFE)16
PRAME expression in melanocytic lesions of the conjunctiva16
Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2‐ rearranged salivary gland tumours16
Novel APODGLI1 rearrangement in a sarcoma of unknown lineage15
Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation15
‘I Can’t Keep Up!’: an update on advances in soft tissue pathology occurring after the publication of the 2020 World Health Organization classification of soft tissue and bone tumours15
Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6NTRK3 fusion, and the rare KLHL7BRAF fusi15
DEVIL, VAAD and vLSC constitute a spectrum of HPV‐independent, p53‐independent intra‐epithelial neoplasia of the vulva15
Update on triple‐negative breast cancers – highlighting subtyping update and treatment implication15
Comparison of different anti‐Ki67 antibody clones and hot‐spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis15
Advances in the classification of round cell sarcomas15
Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer15
Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas15
Why is the histomorphological diagnosis of tumours of minor salivary glands much more difficult?15
Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies15
The role of histopathology in the diagnosis and management of coeliac disease and other malabsorptive conditions15
DNA mismatch repair protein immunohistochemistry – an illustrated guide14
New insights into the classification of gastric neuroendocrine tumours, expanding the spectrum of ECL‐cell tumours related to hypergastrinaemia14
Intratumoral CD103‐positive tumour‐infiltrating lymphocytes are associated with favourable prognosis in patients with triple‐negative breast cancer14
Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences14
Is medullary carcinoma of the colon underdiagnosed? An audit of poorly differentiated colorectal carcinomas in a large national health service teaching hospital14
Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfall14
A novel risk score to predict early and late recurrence in solitary fibrous tumour14
Primary de‐differentiated, trans‐differentiated and undifferentiated melanomas: overview of the clinicopathological, immunohistochemical and molecular spectrum14
Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach14
Pathology updates and diagnostic approaches to haemophagocytic lymphohistiocytosis14
Improving Ki67 assessment concordance by the use of an artificial intelligence‐empowered microscope: a multi‐institutional ring study14
Visual assessment of mitotic figures in breast cancer: a comparative study between light microscopy and whole slide images13
A collaborative workflow between pathologists and deep learning for the evaluation of tumour cellularity in lung adenocarcinoma13
Programmed cell death‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) expression in PD‐1 inhibitor‐associated colitis and its mimics13
High interobserver and intraobserver reproducibility among pathologists assessing PD‐L1 CPS across multiple indications13
Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin‐like enhancer 1 in primary intracranial sarcoma, DICER1‐mutant13
Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR)13
Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management13
Histological features of BRAF V600E‐mutant anaplastic thyroid carcinoma13
Refining the definition of HER2‐low class in invasive breast cancer13
The spectrum of serrated colorectal lesions—new entities and unanswered questions13
Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision13
PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis13
NTRK‐rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation class13
Genomic profile of columnar cell variant of papillary thyroid carcinoma12
What’s new in adipocytic neoplasia?12
Interobserver reproducibility of the diagnosis of differentiated exophytic vulvar intraepithelial lesion (DEVIL) and the distinction from its mimics12
Post‐radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long‐term follow‐up and literature review12
Programmed death‐ligand 1 expression in human papillomavirus‐independent cervical adenocarcinoma and its prognostic significance12
A rare but devastating cause of twin loss in a near‐term pregnancy highlighting the features of severe SARS‐CoV‐2 placentitis12
Novel EGFL7–FOSB fusion in pseudomyogenic haemangioendothelioma with widely metastatic disease12
p16 overexpression and Rb loss correlate with high‐risk HPV infection in oropharyngeal squamous cell carcinoma12
Challenges in Ki‐67 assessments in pulmonary large‐cell neuroendocrine carcinomas*12
NRAS Q61R immunohistochemical staining in thyroid pathology: sensitivity, specificity and utility12
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer12
Lynch syndrome screening in colorectal cancer: results of a prospective 2‐year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2‐million population12
Cystic neutrophilic granulomatous mastitis – a review of 12 consecutive cases12
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study12
The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma12
Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 212
Sclerosing stromal tumour: a clinicopathological study of 100 cases of a distinctive benign ovarian stromal tumour typically occurring in the young12
ALK rearrangements in infantile fibrosarcoma‐like spindle cell tumours of soft tissue and kidney11
Large cell calcifying Sertoli cell tumour: a contemporary multi‐institutional case series highlighting the diagnostic utility of PRKAR1A immunohistochemistry11
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis11
Epstein–Barr virus‐positive inflammatory follicular dendritic cell sarcoma presenting as a solitary colonic mass: two rare cases and a literature review11
MUC4 is expressed in alveolar rhabdomyosarcoma11
Why did they change that? Practical implications of the evolving classification of neuroendocrine tumours of the gastrointestinal tract11
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients11
Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods11
Recent advances in upper gastrointestinal lymphomas: molecular updates and diagnostic implications11
Depth of invasion versus tumour thickness in early oral tongue squamous cell carcinoma: which measurement is the most practical and predictive of outcome?11
Salivary carcinosarcoma: insight into multistep pathogenesis indicates uniform origin as sarcomatoid variant of carcinoma ex pleomorphic adenoma with frequent heterologous elements11
The genetics of vascular tumours: an update11
Increased histologic inflammation is an independent risk factor for nonconventional dysplasia in ulcerative colitis11
NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25‐case cohort study11
Gastrointestinal effects of an attempt to avoid contracting COVID‐19 by ‘disinfection’11
Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours11
Developing consensus in Histopathology: the role of the Delphi method11
A systematic comparison ofpan‐Trkimmunohistochemistry assays among multiple cancer types11
A comparative study of Kimura’s disease and IgG4‐related disease: similarities, differences and overlapping features11
Is nestin a diagnostic marker for combined hepatocellular–cholangiocarcinoma?11
PRRX1–NCOA1‐rearranged fibroblastic tumour: a clinicopathological, immunohistochemical and molecular genetic study of six cases of a potentially under‐recognised, distinctive mesenchymal tumour11
Immunopathology of Kikuchi–Fujimoto disease: A reappraisal using novel immunohistochemistry markers11
The human‐in‐the‐loop: an evaluation of pathologists’ interaction with artificial intelligence in clinical practice11
Molecular and immunohistochemical characterisation of mesothelioma of the tunica vaginalis*11
Histologic characterization of paediatric mesenchymal neoplasms treated with kinase‐targeted therapy11
Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach11
Comprehensive study of nine novel cases of TFEB‐amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression10
PTEN expression and morphological patterns in prostatic adenocarcinoma10
Mesonephric‐like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas10
Clinicopathological analysis of low‐grade papillary Schneiderian carcinoma: report of five new cases and review of the literature10
Immunohistochemical detection of citrullinated histone H3‐positive neutrophils is useful for identifying active glomerular and interstitial lesions in antineutrophil cytoplasmic antibody‐associated va10
Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP)10
Sporadic superficial angiomyxomas demonstrate loss of PRKAR1A expression10
Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1‐deficient skin carcinoma10
YAP1–TFE3 gene fusion variant in clear cell stromal tumour of lung: report of two cases in support of a distinct entity10
Clinicopathologic features of undetected dysplasia found in total colectomy or proctocolectomy specimens of patients with inflammatory bowel disease10
Clinical and histopathological features of pulmonary sclerosing pneumocytoma with dense spindle stromal cells and lymph node metastasis10
Onychomatricoma: a clinicopathological, immunohistochemical, and molecular study of 10 cases highlighting recurrent RB1 deletion and the potential diagnostic value of LEF‐110
Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix10
Switch/sucrose‐non‐fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)‐deficient colorectal carcinomas are strongly associa10
Molecular pathology of skin adnexal tumours10
H3F3A‐mutated giant cell tumour of bone without giant cells—clinical presentation, radiology and histology of three cases10
RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps10
Development of a semi‐automated method for tumour budding assessment in colorectal cancer and comparison with manual methods10
Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer10
Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitonea10
The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breast10
Artificial intelligence in breast cancer histopathology10
Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2‐tier nuclear grade10
Diversity in cell differentiation, histology, phenotype and vasculature of mass‐forming intrahepatic cholangiocarcinomas10
Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies9
A comparative study of AJCC and the modified staging system in pT2/pT3 penile squamous cell carcinoma – a validation on an external data set9
Establishing diagnostic criteria for mastocytosis in skin biopsies9
The solid variant of papillary thyroid carcinoma: a multi‐institutional retrospective study9
Ovarian seromucinous cystadenomas and adenofibromas: first report of a case series9
A simple digital image analysis system for automated Ki67 assessment in primary breast cancer9
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia9
SWI/SNF protein and claudin‐4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum9
Recent developments in gastroesophageal mesenchymal tumours9
Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiation9
PIN‐like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations9
Digital image analysis and assisted reading of the HER2 score display reduced concordance: pitfalls in the categorisation of HER2‐low breast cancer9
Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma9
Use of p53 immunohistochemistry in conjunction with routine histology improves risk stratification of patients with Barrett’s oesophagus during routine clinical care9
Cutaneous manifestations of lupus erythematosus: a practical clinicopathological review for pathologists9
Lymphoepithelioma‐like neoplasm of the biliary tract with ‘probable low malignant potential’9
Risk factors for progression of appendiceal neuroendocrine tumours: low‐stage tumours <5 mm appear to be overwhelmingly indolent and may merit a separate designation9
Clinicopathological, immunohistochemical and fluorescence in‐situ hybridisation features of early subungual melanoma: an analysis of 65 cases9
Survey of recurrent diagnostic challenges in breast phyllodes tumours9
Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study9
Ovarian microcystic stromal tumour: from morphological observations to syndromic associations9
Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry9
Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma9
Somatic tumour testing establishes that bilateral DICER1‐associated ovarian Sertoli–Leydig cell tumours represent independent primary neoplasms9
Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence9
Primary synovial sarcoma of bone: a retrospective analysis of 25 patients9
TROP2, androgen receptor, and PD‐L1 status in histological subtypes of high‐grade metaplastic breast carcinomas9
Diagnostic test accuracy meta‐analysis of PRAME in distinguishing primary cutaneous melanomas from benign melanocytic lesions9
Concordance between core needle biopsy and surgical excision specimens for Ki‐67 in breast cancer – a systematic review of the literature9
Evaluation oncotype DX® 21‐gene recurrence score and clinicopathological parameters: a single institutional experience9
Whole‐exome analysis of metaplastic breast carcinomas with extensive osseous differentiation8
Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms8
Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance8
Non‐conventional dysplasia is frequently associated with low‐grade tubuloglandular and mucinous adenocarcinomas in inflammatory bowel disease8
Hypothesis: HEG1 and claudin‐4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus non‐small‐cell lung carcinoma with only two stains in most cases8
Epithelioid sarcoma with retained INI1 (SMARCB1) expression8
Epstein–Barr virus‐associated large B‐cell lymphoma transformation in marginal zone B‐cell lymphoma: a series of four cases8
Stromal composition predicts recurrence of early rectal cancer after local excision8
0.045449018478394